Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Midodrine for the Treatment of Refractory Hypotension

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by Massachusetts General Hospital
Information provided by (Responsible Party):
Matthias Eikermann, Massachusetts General Hospital Identifier:
First received: February 9, 2012
Last updated: March 29, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)